Barr earns $32.5 million to close 2007
-
- February
- 28
Barr Pharmaceuticals Inc., the company with research operations in Pomona, earned $32.5 million, or 30 cents a share, during the fourth quarter of last year.
Revenues were $668.7 million, the company reported this morning.
In the fourth quarter of calendar year 2006, Barr, the parent company of Rockland-based Barr Laboratories Inc., changed its fiscal year to end on Dec. 31 instead of June 30. Also, in October 2006, Barr bought Pliva d.d., a Croatian generics pharmaceutical company, for $2.4 billion.
Because of these two moves, the comparison of year-to-year figures is not meaningful, the company said.
Barr shares rose 50 cents yesterday to close at $49.19.
This entry was posted
on Thursday, February 28th, 2008 at 8:55 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Category: Earnings season
Print
| 
Email
